95 related articles for article (PubMed ID: 10389594)
21. The use of flow cytometry to detect minimal residual disease in acute leukemia.
Campana D; Coustan-Smith E
Eur J Histochem; 1996; 40 Suppl 1():39-42. PubMed ID: 8839698
[No Abstract] [Full Text] [Related]
22. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.
Liang DC; Shih LY; Fu JF; Li HY; Wang HI; Hung IJ; Yang CP; Jaing TH; Chen SH; Liu HC
Cancer; 2006 Feb; 106(4):950-6. PubMed ID: 16404744
[TBL] [Abstract][Full Text] [Related]
23. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
[TBL] [Abstract][Full Text] [Related]
24. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
Sinclair P; Harrison CJ; Jarosová M; Foroni L
Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
[TBL] [Abstract][Full Text] [Related]
25. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal.
Kaleem Z; White G
Am J Clin Pathol; 2001 Jun; 115(6):876-84. PubMed ID: 11392885
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
28. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
Leong CF; Kalaichelvi AV; Cheong SK; Hamidah NH; Rahman J; Sivagengei K
Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
[TBL] [Abstract][Full Text] [Related]
29. Acute biphenotypic leukemia in the adults.
Shen Y; Li J; Xue Y; Zhu M; Lu D; Geng M; Ruan C
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):375-7. PubMed ID: 12408768
[TBL] [Abstract][Full Text] [Related]
30. Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia.
Moon Y; Kim Y; Kim M; Lim J; Kang CS; Kim WI; Shim SI; Chung NG; Park YH; Min WS; Han K
Ann Clin Lab Sci; 2004; 34(4):410-5. PubMed ID: 15648782
[TBL] [Abstract][Full Text] [Related]
31. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.
Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S
Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
[TBL] [Abstract][Full Text] [Related]
33. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
34. Frequent but nonrandom expression of lymphoid markers on de novo childhood acute myeloid leukemia.
Abdelhaleem M
Exp Mol Pathol; 2007 Oct; 83(2):259-63. PubMed ID: 17662713
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow examination in the diagnosis of acute and chronic leukemias.
Foucar K
Hematol Oncol Clin North Am; 1988 Dec; 2(4):567-84. PubMed ID: 3065319
[TBL] [Abstract][Full Text] [Related]
36. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
37. Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
Kern W; Danhauser-Riedl S; Ratei R; Schnittger S; Schoch C; Kolb HJ; Ludwig WD; Hiddemann W; Haferlach T
Haematologica; 2003 Jun; 88(6):646-53. PubMed ID: 12801840
[TBL] [Abstract][Full Text] [Related]
38. p-Iodophenol-enhanced luminol chemiluminescent assay applied to discrimination between acute lymphoblastic and minimally differentiated acute myeloid (FAB-M0) or acute megakaryoblastic (FAB-M7) leukemias.
da Costa M; Ximenes VF; Brunetti IL; Falcão RP; da Fonseca LM
Hematol J; 2004; 5(6):496-9. PubMed ID: 15570291
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometry measurement of cytokine receptors in acute leukemias. Clinical and biologic implications.
Lanza F; Moretti S; Castagnari B; Latorraca A; Focarile E; Ferrari L; Castoldi GL
Eur J Histochem; 1997; 41 Suppl 2():25-6. PubMed ID: 9859767
[No Abstract] [Full Text] [Related]
40. [Detection of minimal residual disease in acute leukemias by flow cytometry].
Scolnik MP
Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
